• Thumbnail for QazCovid-in
    QazCovid-in, commercially known as QazVac, is a COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan. QazCoVac-P...
    10 KB (828 words) - 05:52, 24 September 2024
  • Belarus Cambodia Russia Travel-only Malaysia New Zealand Turkey QazCovid-in, also known as QazVac, is an inactivated virus vaccine developed by the Research...
    322 KB (19,558 words) - 03:33, 16 September 2024
  • Thumbnail for Inactivated vaccine
    vaccine Some COVID-19 vaccines: CoronaVac, Covaxin, QazVac, Sinopharm BIBP, Sinopharm WIBP, TURKOVAC, CoviVac Bacterial: Injected typhoid vaccine Cholera...
    14 KB (1,234 words) - 14:51, 22 June 2024
  • President of the Kazakh Academy of Sciences. Zakaryia is a developer of the QazVac (QazCovid-in) vaccine candidate against COVID-19. Born to a family of an engineer...
    12 KB (734 words) - 19:38, 20 August 2024
  • Chinese CoronaVac and the Sinopharm BIBP and WIBP vaccines; there is also the Indian Covaxin, the Russian CoviVac, the Kazakh vaccine QazVac, and the Iranian...
    202 KB (22,928 words) - 23:44, 14 October 2024
  • Thumbnail for COVID-19 vaccine clinical research
    Chinese Academy of Medical Sciences, CoronaVac, Covaxin, CoviVac, COVIran Barekat, FAKHRAVAC, Minhai-Kangtai, QazVac, Sinopharm BIBP, WIBP, Turkovac, and VLA2001...
    95 KB (18,965 words) - 23:35, 15 September 2024
  • Thumbnail for COVID-19 vaccination in Kazakhstan
    institute reported 96% efficiency rate of QazCovid-in. Kazakhstan has created its own COVID-19 vaccination, QazCovid-in, developed by the Research Institute...
    14 KB (839 words) - 20:32, 16 May 2024
  • Chinese Academy of Medical Sciences CoronaVac Covaxin COVIran Barekat CoviVac (Russia) FAKHRAVAC Minhai QazCovid-in Sinopharm BIBP Sinopharm WIBP Turkovac...
    180 KB (23,898 words) - 14:59, 19 August 2024